Kottil Rammohan
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (44.5%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by EMD Serono, Inc. at 36.4% of the total. Reporting peaked in 2019 at $43,597 and has fallen 76.2% since, to $10,363 in 2025. Among neurology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 270 payments — averaging $650.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- EMD Serono, Inc.$64K
- Genentech USA, Inc.$23K
- Novartis$20K
- TG Therapeutics, Inc.$10K
- AstraZeneca$10K
- Biogen$9K
- plus $38K from 13 others
Across 468 payments — averaging $10,277 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$1.6M
- AstraZeneca$760K
- Genentech, Inc.$657K
- Novartis$459K
- Sanofi$454K
- Biogen$300K
- plus $571K from 6 others
What the payments were for
- Consulting fees$78,18344%
- Speaking & faculty fees$60,77135%
- Travel & lodging$11,7937%
- Food & beverage$12,7007%
- Education$12,1047%
- Gifts$1800%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| EMD Serono, Inc. | 89 | $63,987 |
| Genentech USA, Inc. | 21 | $23,079 |
| Novartis | 40 | $20,262 |
| TG Therapeutics, Inc. | 8 | $10,489 |
| AstraZeneca | 17 | $10,274 |
| Biogen | 25 | $9,420 |
| Amgen(2 entities) | 17 | $7,765 |
| Genentech, Inc. | 8 | $7,472 |
| Merck Kgaa | 3 | $6,880 |
| Sanofi | 15 | $6,781 |
| F. Hoffmann-la Roche AG | 1 | $5,270 |
| Novartis Pharma AG | 1 | $1,410 |
| Bristol Myers Squibb | 14 | $1,097 |
| Hexal AG | 1 | $940 |
| Saol Therapeutics Inc. | 2 | $180 |
| Sandoz | 4 | $162 |
| Axonics, Inc. | 1 | $146 |
| Johnson & Johnson | 2 | $100 |
| Banner Life Sciences, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$175,730 in reported general payments places this provider in the 95th percentile of 1,434 neurology providers in Florida.
Other neurology in Miami
- Diego Torres-RussottoMiami$652K
- Bruno GalloMiami$313K
- Brad HerskowitzMiami$273K
- Flavia NelsonMiami$264K
- Corneliu LucaMiami$257K
- Stuart IsaacsonBoca Raton$3.9M
- Selim BenbadisTampa$2.1M
- Derrick RobertsonTampa$1.8M
- Robert HauserTampa$1.6M
- David RoseTampa$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.